Cargando…

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD

BACKGROUND: Pentraxin 3 (PTX3) is an acute phase protein, involved in antibacterial resistance. Recent studies have shown PTX3 levels to be elevated in the presence of a bacterial infection and in a murine sepsis model. OBJECTIVE: We aim to investigate if sputum PTX3 can be used as a biomarker for b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thulborn, Samantha J, Dilpazir, Madiha, Haldar, Koirobi, Mistry, Vijay, Brightling, Christopher E, Barer, Michael R, Bafadhel, Mona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402921/ https://www.ncbi.nlm.nih.gov/pubmed/28458531 http://dx.doi.org/10.2147/COPD.S123528

Ejemplares similares

Neutrophil elastase as a biomarker for bacterial infection in COPD
por: Thulborn, Samantha J., et al.
Publicado: (2019)

Detection of Cell-Dissociated Non-Typeable Haemophilus influenzae in the Airways of Patients with Chronic Obstructive Pulmonary Disease
por: Thulborn, Samantha J, et al.
Publicado: (2020)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
por: Bafadhel, Mona, et al.
Publicado: (2015)

Sputum Moraxella catarrhalis strains exhibit diversity within and between COPD subjects
por: George, Leena M, et al.
Publicado: (2018)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations
por: Barker, Bethan L., et al.
Publicado: (2015)

Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics
por: Haldar, Koirobi, et al.
Publicado: (2017)

Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease
por: Barker, Bethan L, et al.
Publicado: (2014)

Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab
por: George, Leena, et al.
Publicado: (2019)

Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD
por: Bafadhel, Mona, et al.
Publicado: (2011)

Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus‐predominant subgroup
por: Diver, Sarah, et al.
Publicado: (2019)

The sputum microbiome is distinct between COPD and health, independent of smoking history
por: Haldar, Koirobi, et al.
Publicado: (2020)

Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV(1)
por: Cane, Jennifer, et al.
Publicado: (2021)

Face mask sampling reveals antimicrobial resistance genes in exhaled aerosols from patients with chronic obstructive pulmonary disease and healthy volunteers
por: Kennedy, Matthew, et al.
Publicado: (2018)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
por: Eltboli, Osama, et al.
Publicado: (2014)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
por: Siva, Roshan, et al.
Publicado: (2014)

Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles
por: Ghebre, Michael A., et al.
Publicado: (2018)

Expression of the T Helper 17-Associated Cytokines IL-17A and IL-17F in Asthma and COPD
por: Doe, Camille, et al.
Publicado: (2010)

Inflammatory Endotype–associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis
por: Wang, Zhang, et al.
Publicado: (2021)

The Role of CT Scanning in Multidimensional Phenotyping of COPD
por: Bafadhel, Mona, et al.
Publicado: (2011)

Renaming COPD exacerbations: the UK respiratory nursing perspective
por: Mwasuku, Christine, et al.
Publicado: (2021)

Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
por: David, Benjamin, et al.
Publicado: (2021)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
por: Camp, James, et al.
Publicado: (2018)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
por: Hambleton, Kirsty, et al.
Publicado: (2017)

Eosinophilic airway inflammation in COPD
por: Saha, Shironjit, et al.
Publicado: (2006)

High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis
por: Chakrabarti, Arindam, et al.
Publicado: (2021)

Pentraxin 3: A Novel Biomarker for Inflammatory Cardiovascular Disease
por: Inoue, Kenji, et al.
Publicado: (2012)

The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis
por: He, Qian, et al.
Publicado: (2021)

Aerobic Training Down-Regulates Pentraxin 3 and Pentraxin 3/Toll-Like Receptor 4 Ratio, Irrespective of Oxidative Stress Response, in Elderly Subjects
por: Estébanez, Brisamar, et al.
Publicado: (2020)

Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
por: Singh, Dave, et al.
Publicado: (2021)

Blood and sputum eosinophils in COPD; relationship with bacterial load
por: Kolsum, Umme, et al.
Publicado: (2017)

Building toolkits for COPD exacerbations: lessons from the past and present
por: Sapey, Elizabeth, et al.
Publicado: (2019)

Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
por: Liu, Siguan, et al.
Publicado: (2014)

Pentraxin-3 and inflammatory biomarkers related to posterolateral thoracotomy in Thoracic Surgery
por: Dongel, Isa, et al.
Publicado: (2019)

Editorial: The Role of Pentraxins: From Inflammation, Tissue Repair and Immunity to Biomarkers
por: Bottazzi, Barbara, et al.
Publicado: (2019)

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Regulation of pentraxin-3 by antioxidants
por: Hill, A. L., et al.
Publicado: (2009)

Pentraxins in Complement Activation and Regulation
por: Ma, Ying Jie, et al.
Publicado: (2018)

Regulation of the Complement System by Pentraxins
por: Haapasalo, Karita, et al.
Publicado: (2019)

Pentraxin 3 in Cardiovascular Disease
por: Ristagno, Giuseppe, et al.
Publicado: (2019)

Pentraxin-3, Interleukin-6, and Acute Appendicitis: Biomarkers That Need Further Exploration
por: Abouhamda, Ayman
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fbbmtfg0guf1ou5k3l5i5jcjon